Financials Arecor Therapeutics plc

Equities

AREC

GB00BMWLM973

Biotechnology & Medical Research

Delayed London S.E. 07:59:59 19/07/2024 BST 5-day change 1st Jan Change
92.5 GBX 0.00% Intraday chart for Arecor Therapeutics plc -12.74% -49.32%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 111.3 73.48 55.89 28.33 - -
Enterprise Value (EV) 1 93.02 60.68 55.89 27.69 28.84 24.1
P/E ratio -14.8 x -7.5 x -6.52 x -5.14 x -9.25 x -
Yield - - - - - -
Capitalization / Revenue 96.1 x 30.6 x 12.2 x 3.78 x 2.5 x 1.92 x
EV / Revenue 80.3 x 25.3 x 12.2 x 3.7 x 2.54 x 1.63 x
EV / EBITDA -14.8 x -5.9 x -6.44 x -4.77 x -8.22 x -16.1 x
EV / FCF - -5.48 x - -5.24 x -8.67 x -
FCF Yield - -18.3% - -19.1% -11.5% -
Price to Book - 4.21 x - 7.13 x 61.5 x -
Nbr of stocks (in thousands) 27,835 30,618 30,627 30,627 - -
Reference price 2 4.000 2.400 1.825 0.9250 0.9250 0.9250
Announcement Date 25/04/22 20/04/23 16/05/24 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 1.158 2.403 4.573 7.487 11.33 14.76
EBITDA 1 - -6.268 -10.29 -8.679 -5.805 -3.507 -1.5
EBIT 1 - -6.439 -10.63 -9.175 -6.249 -3.894 -1.73
Operating Margin - -556.04% -442.36% -200.63% -83.46% -34.36% -11.72%
Earnings before Tax (EBT) 1 - -6.945 -10.54 -8.901 -6.65 -4.235 -2.48
Net income 1 -2.752 -6.169 -9.26 -8.554 -6.01 -3.766 -
Net margin - -532.73% -385.35% -187.05% -80.28% -33.23% -
EPS 2 -1.020 -0.2700 -0.3200 -0.2800 -0.1800 -0.1000 -
Free Cash Flow 1 - - -11.08 - -5.289 -3.328 -
FCF margin - - -461.05% - -70.64% -29.36% -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share 2 - - - - - - -
Announcement Date 01/07/21 25/04/22 20/04/23 16/05/24 - - -
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - 0.51 -
Net Cash position 1 - 18.3 12.8 - 0.64 - 4.23
Leverage (Debt/EBITDA) - - - - - -0.1445 x -
Free Cash Flow 1 - - -11.1 - -5.29 -3.33 -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 - - 0.5700 - 0.1300 0.0200 -
Cash Flow per Share - -0.2400 -0.3700 - - - -
Capex 1 - 0.07 0.3 - 0.13 0.19 -
Capex / Sales - 5.96% 12.44% - 1.78% 1.65% -
Announcement Date 01/07/21 25/04/22 20/04/23 16/05/24 - - -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.925 GBP
Average target price
5.007 GBP
Spread / Average Target
+441.26%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AREC Stock
  4. Financials Arecor Therapeutics plc